Marshall Wace North America’s Teladoc Health TDOC Stock Holding History

Marshall Wace North America’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$6.8M	Buy	53,625 +29,099	+119%	+$4.24M	0.03%	433
2021 Q2	$4.08M	Sell	24,526 -58,765	-71%	-$9.52M	0.02%	607
2021 Q1	$15.1M	Buy	83,291 +71,231	+591%	+$16.5M	0.06%	317
2020 Q4	$2.41M	Buy	12,060 +7,249	+151%	+$1.47M	0.01%	707
2020 Q3	$1.05M	Buy	+4,811	New	+$1.02M	0.01%	786
2020 Q2	–	Sell	-8,346	Closed	-$1.29M	–	1472
2020 Q1	$1.29M	Buy	+8,346	New	+$971K	0.01%	567
2019 Q3	–	Sell	-34,926	Closed	-$2.32M	–	1546
2019 Q2	$2.32M	Buy	34,926 +34,296	+5,444%	+$2M	0.01%	533
2019 Q1	$35K	Buy	+630	New	+$38.5K	﹤0.01%	1319
2018 Q4	–	Sell	-202,001	Closed	-$17.4M	–	1628
2018 Q3	$17.4M	Buy	202,001 +153,146	+313%	+$10.9M	0.12%	152
2018 Q2	$2.84M	Buy	+48,855	New	+$2.39M	0.02%	677
2017 Q4	–	Sell	-113,562	Closed	-$3.75M	–	1602
2017 Q3	$3.75M	Buy	+113,562	New	+$3.72M	0.02%	629

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

Marshall Wace North America's TDOC Position: Q3 2021 in Review

Marshall Wace North America increased its Teladoc Health (TDOC) stake by 119% in Q3 2021, buying an estimated $4.24M and bringing the position to 53,625 shares worth $6.8M. The position accounts for 0.03% of the portfolio, ranked #433.

Marshall Wace North America first reported a position in TDOC in Q3 2017 and has held it in 11 quarters since. The position peaked at $17.4M in Q3 2018. 761 funds tracked by Wall St. Rank hold TDOC as of Q3 2021.

Marshall Wace North America held 53,625 shares of Teladoc Health worth $6.8M as of Q3 2021.
Marshall Wace North America bought 29,099 Teladoc Health shares in Q3 2021, an estimated $4.24M.
Teladoc Health made up 0.03% of Marshall Wace North America's portfolio in Q3 2021, its #433 holding.
Marshall Wace North America first reported a position in Teladoc Health in Q3 2017 and has held it in 11 quarters since.
Marshall Wace North America's Teladoc Health position peaked at $17.4M in Q3 2018.
761 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.